Lumotao, Lita .
HRN: 27-53-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2025
CEFTRIAXONE 1G (VIAL)
07/28/2025
08/03/2025
IV
2g
Od
Cap
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: